Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest Content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest Content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 98, Issue 1156
‘Triple therapy’ (elexacaftor, tezacaftor, ivacaftor) skin rash in patients with cystic fibrosis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Adverse drug reactions
‘Triple therapy’ (elexacaftor, tezacaftor, ivacaftor) skin rash in patients with cystic fibrosis
Online download statistics by month:
Online download statistics by month: December 2020 to June 2022
Abstract
Full
Pdf
Dec 2020
480
31
20
Jan 2021
287
18
6
Feb 2021
184
2
7
Mar 2021
243
9
9
Apr 2021
190
13
6
May 2021
171
16
6
Jun 2021
11
5
3
Jul 2021
32
16
9
Aug 2021
33
13
10
Sep 2021
37
19
6
Oct 2021
152
14
4
Nov 2021
171
18
5
Dec 2021
187
8
4
Jan 2022
690
34
8
Feb 2022
400
34
15
Mar 2022
310
41
16
Apr 2022
214
18
8
May 2022
291
9
4
Jun 2022
296
29
9
Total
4379
347
155
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF